Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Pharmacotherapy ; 39(10): 994-1004, 2019 10.
Artigo em Inglês | MEDLINE | ID: mdl-31411762

RESUMO

OBJECTIVES: Few studies have investigated the prophylactic efficacy of dexmedetomidine (DEX) in postpartum depressive symptoms (PDS). A randomized double-blind placebo-controlled trial was conducted to investigate whether the administration of DEX, immediately after delivery and for patient-controlled intravenous analgesia (PCIA), can attenuate PDS. METHODS: A total of 600 parturients scheduled for elective cesarean delivery under spinal anesthesia were randomly allocated into the control group (infusion with 0.9% normal saline after delivery and PCIA with sufentanil) and the DEX group (DEX infusion 0.5 µg/kg after delivery and PCIA with DEX plus sufentanil). The prevalence of postpartum depressive disorders was indicated by the Edinburgh Postnatal Depression Scale (EPDS). Postoperative analgesia, sedation, and sleep quality of parturients were also assessed. RESULTS: Postpartum blues and PDS prevalence in the DEX, versus control, group were significantly lower (5.0% vs 14.1%, p<0.001; 5.7% vs 16.3%, p<0.001, respectively), especially in parturients with antenatal depression or moderate stress during pregnancy. Compared with the control group, the EPDS score at postpartum days 7 and 42 in the DEX group was significantly lower (4.23 ± 4.37 vs 1.93 ± 3.36, p<0.001; 4.68 ± 4.78 vs 1.99 ± 3.18, p<0.001, respectively), as was the incidence of postpartum self-harm ideation at postpartum days 7 and 42 in the DEX group versus the control group (1.1% vs 4.0%, p=0.03; 0.4% vs 2.9%, p=0.04, respectively). The pain score and the sleep quality in the DEX group were better than that in the control group (p<0.001). CONCLUSION: The application of DEX in the early postpartum period can significantly attenuate the incidence of postpartum depressive disorders.


Assuntos
Analgesia Obstétrica , Cesárea , Depressão Pós-Parto/prevenção & controle , Dexmedetomidina/administração & dosagem , Adulto , Analgesia Obstétrica/efeitos adversos , Analgesia Obstétrica/métodos , Analgésicos não Narcóticos/administração & dosagem , Cesárea/efeitos adversos , Cesárea/métodos , Depressão Pós-Parto/diagnóstico , Depressão Pós-Parto/epidemiologia , Método Duplo-Cego , Feminino , Humanos , Incidência , Avaliação de Resultados em Cuidados de Saúde , Gravidez , Escalas de Graduação Psiquiátrica , Higiene do Sono/efeitos dos fármacos
2.
Psychiatry Res ; 279: 252-258, 2019 09.
Artigo em Inglês | MEDLINE | ID: mdl-31147085

RESUMO

This study aimed to explore the effect of prophylactic ketamine administration on postpartum depression in Chinese woman undergoing cesarean section. This randomized controlled study included 654 Chinese women undergoing cesarean section. At 10 min after child birth, patients in the ketamine group were given 0.5 mg/kg ketamine, whereas patients in the control group received standard postpartum care. At the end of operation, all patients were armed with a patient-controlled intravenous analgesia device. The primary outcome was the prevalence of postpartum depression (PPD), as assessed by the Edinburgh Postnatal Depression Scale (EPDS), and the secondary outcomes included the safety assessment and the Numerical Rating Scale (NRS) of postoperative pain. The prevalence of postpartum blues and postpartum depression were significantly lower in the ketamine group than in the control group. Logistic analysis showed that ketamine administration protected against postpartum depression, and PPD-associated risk factors included stress during pregnancy, antenatal depressive symptom and antenatal suicidal ideation. In addition, the antidepressive effect of prophylactic ketamine was stronger in mothers with a history of moderate stress during pregnancy, antenatal depressive symptom and antenatal suicidal ideation. Our findings suggest that ketamine functions as a prophylactic agent against PPD.


Assuntos
Povo Asiático/psicologia , Cesárea/psicologia , Depressão Pós-Parto/tratamento farmacológico , Depressão Pós-Parto/psicologia , Antagonistas de Aminoácidos Excitatórios/administração & dosagem , Ketamina/administração & dosagem , Adulto , Cesárea/tendências , Depressão Pós-Parto/diagnóstico , Esquema de Medicação , Feminino , Humanos , Mães/psicologia , Gravidez , Escalas de Graduação Psiquiátrica , Fatores de Risco , Método Simples-Cego
3.
Arch Womens Ment Health ; 22(3): 339-348, 2019 06.
Artigo em Inglês | MEDLINE | ID: mdl-30121843

RESUMO

Postpartum depressive symptoms (PDS) are not an uncommon mood disorder in postpartum women. Our previous research indicated a role for increased tryptophan (TRP) metabolism along the kynurenine pathway (KP) in the pathogenesis of PDS. Accordingly, this study was going to investigate the association of indoleamine-2,3-dioxygenase (IDO, a key enzyme of KP) genetic polymorphisms with PDS. Seven hundred twenty-five women receiving cesarean section were enrolled in this study. PDS was determined by an Edinburgh Postnatal Depression Scale (EPDS) score ≥ 13. Subsequently, 48 parturients with PDS and 48 parturients without PDS were selected for investigation of perinatal serum concentrations of TRP, kynurenine (KYN), and KYN/TRP ratio, the latter is the representative of IDO activity. In addition, seven single nucleotide polymorphisms of the IDO gene were examined. Following this genotyping, 50 parturients carrying the IDO rs10108662 AA genotype and 50 parturients carrying the IDO rs10108662 AC + CC genotype were selected for comparisons of TRP, KYN, and KYN/TRP ratio levels. This study showed the PDS incidence of 6.9% in the Chinese population, with PDS characterized by increased IDO activity (p < 0.05), versus women without PDS. We also found that the variations of IDO1 gene rs10108662 were significantly related to PDS incidence (p < 0.05). Furthermore, there was a significant difference in IDO activity between the IDO rs10108662 CA + AA, versus CC, genotypes. Our findings indicate a role of the kynurenine pathway in the development of PDS, rs10108662 genetic polymorphism resulting in changes of IDO activity might contribute to PDS pathogenesis.


Assuntos
Cesárea/psicologia , Depressão Pós-Parto/genética , Indolamina-Pirrol 2,3,-Dioxigenase/genética , Polimorfismo de Nucleotídeo Único , Adulto , Povo Asiático/estatística & dados numéricos , Estudos de Casos e Controles , China/epidemiologia , Depressão Pós-Parto/epidemiologia , Feminino , Genótipo , Humanos , Cinurenina/sangue , Gravidez , Triptofano/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA